On Invalid Date, Heart Test Laboratories (NASDAQ: HSCS) reported Q4 2023 earnings per share (EPS) of -$0.03, up 81.25% year over year. Total Heart Test Laboratories earnings for the quarter were -$1.64 million. In the same quarter last year, Heart Test Laboratories's earnings per share (EPS) was -$0.16.
As of Q2 2024, Heart Test Laboratories's earnings has grown year over year. Heart Test Laboratories's earnings in the past year totalled -$6.39 million.
What was HSCS's revenue last quarter?
On Invalid Date, Heart Test Laboratories (NASDAQ: HSCS) reported Q4 2023 revenue of $14.70 thousand up 653.85% year over year. In the same quarter last year, Heart Test Laboratories's revenue was $1.95 thousand.
What was HSCS's revenue growth in the past year?
As of Q2 2024, Heart Test Laboratories's revenue has grown 100.02% year over year. This is 90.55 percentage points higher than the US Medical Devices industry revenue growth rate of 9.47%. Heart Test Laboratories's revenue in the past year totalled $18.60 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.